Drugs of Abuse Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Substance Use Disorder

A
  • A problematic pattern of use leading to significant impairment or distress
  • Pharmacological profile of the abused agent < Psychosocial aspects driving the abuse
  • Cluster of cognitive, behavioral, and physiological sx indicating that the individual continues using the substance despite significant substance related problems
  • Drug seeking behavior is a critical element of substance abuse disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Innate Tolerance

A

Pre-existent tolerance due to genetic variability

Individuals w/ lower innate sensitivity to ethanol are at higher risk for alcoholism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acquired Tolerance

A
  • ↓ Effect of a substance that develops after continued use
  • Dose response curve shifts right ⇒ more substance is required to achieve the same effect
  • Drug toxicity curve shifts less than the psychopharmacological effect
    • Ex. Opiods: brain respiratory centers tolerance < psychopharmacologic effects ⇒ pt ↑ dose to achieve the same effect ⇒ ↑ risk of respiratory depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharmacokinetic Tolerance

A

Body’s ↑ capacity to metabolize or excrete the drugs

Ex. chronic ethanol consumption ⇒ induction of the mixed ethanol microsomal oxidizing system (cytochrome p450 system) ⇒ ↓ levels of ethanol in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacodynamic Tolerance

A

Refers to neuronal adaptation, resulting in a reduced response to the substance

Degree of tolerance via this mechanism is much greater than pharmacokinetic tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Short-term

Pharmacodynamic Tolerance

A

Refers to neuronal adaptation, resulting in a reduced response to the substance

Short-term tolerance in neurotransmitter release or receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Long-term

Pharmacodynamic Tolerance

A

Refers to neuronal adaptation, resulting in a reduced response to the substance.

Long-term toleranceneuroadaptive changes 2/2 gene expression responsible for the action of the drug

May explain the cravings that occur after the drug has been discontinued

ETOH example:

  • ETOH acutely ⊕ GABA receptors and ⊗ NMDA receptors
    • Leads to dec. excitability
  • Long-term exposure
    • ∆ in subunit structure of GABA receptors ⇒ dec. sensitivity
    • Phosphorylation of NMDA receptors ⇒ enhanced conduction Ca2+
  • Changes are in the opposite direction of the acute effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Learned Tolerance

A

There are two types:

  • Behavioral Tolerance
    • Changes in behavior to accommodate to the drug’s effects
  • Conditioned Tolerance
    • Environmental cues associated w/ the drug, which elicit reflexive compensatory changes
    • Ex. drug paraphernalia may elicit pre-emptory compensatory changes to counteract the drug
    • A drug taken in a familiar environment may have a lethal effect if taken in an unfamiliar environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Physical Dependence

A

Related to tolerance and neuroadaptation

  • Substance use disorders ⇒ need the drug to be present to maintain “near” normal functioning
  • Removal of drug ⇒ an acute w/d syndrome
    • Lasts days while the system is re-equilibrating to the absence of drug
    • Acute phase is mediated by signal transduction systems at the cellular level
  • After the acute phase, a protracted w/d syndrome occurs which may continue indefinitely
    • Manifested as craving for the drug
    • Likely due to dysregulation of learning and reward systems in the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Psychological Dependence

A
  • This type of dependence is mediated by a common neuronal pathway that leads to reinforcement
  • All drugs of abuse ↑ dopamine release from ventral tegmental areanucleus accumbens
  • Peak of dopamine release in the nucleus accumbens corresponds w/ peak drug effect on CNS
  • Important in the brain reward pathway, ⊕ of nucleus accumbens reinforces motivated behavior and learning/memory via links to other parts of the brain
  • Long-term dependence after w/d is over due to an
  • *interaction between the reward and memory circuitry**
  • Cues in the environment can generate intense cravings and relapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Substance Use Disorders

Factors

A

Variables affecting development:

  • Pharmacokinetics
    • The more rapid the rise of drugs in the brain, the
  • *greater activation of reward pathways**
    • Heroin rapidly enters the brain ⇒ more addictive than morphine
    • Cocaine:
      • Chewing on coca leaves has a relatively low potential for addiction
      • Inhaling extracted cocaine through the nasal mucosa is more reinforcing
      • The most reinforcing and therefore, most addictive are intravenous injections or inhalation of smoked freebase
      • This leads to the most rapid rise in cocaine concentration
  • Genetics
    • Most studied in alcoholism
      • Inheritance may account for 50-60% of variability in this disorder
    • Polymorphisms in alcohol dehydrogenase and acetaldehyde dehydrogenase ⇒ ↑ levels of acetaldehyde ⇒ flushing and other sx which are aversive
    • Individuals w/ this polymorphism would be less likely to develop alcoholism
  • Psychiatric Disorders
    • Association between psychiatric disorders and substance abuse disorders
    • Individuals w/ major depressive disorders are 2-3x more likely to have a substance abuse disorder
    • A large proportion of addicts self-medicate to reduce distress associated w/ co-occurring psychiatric and medical disorders
    • These conditions are then further exacerbated by the continued substance abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Opioids

A
  • CNS Depressant
  • Multiple inputs into the reward circuits of the brain
  • Opioids are co-abused w/ other drugs w/ different pharmacological actions
    • Heroin + cocaine = “speedball”
  • Shows significant tolerance
  • Drug should be tapered when discontinued to avoid severe w/d sx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Barbiturates and Benzodiazepines

A
  • CNS Depressant
  • Euphoric feelings occur early in intoxication and may contribute to the abuse potential
  • Anxiolytic properties may also contribute to their abuse liability
  • Often co-abused w/ other drugs, e.g. ethanol
    • Combo w/ ethanol can cause respiratory depression and death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alcohol

A
  • CNS Depressant
  • Alcoholism is the most prevalent drug problem in the US, because it is readily available, affordable and legal
  • It has complex mechanism of action, involving GABA, NMDA, and cannabinoid receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nicotine

Overview

A

CNS stimulant

  • Mechanism of Action:
    • Activates nicotinic receptors in the body, CNS, periphery, and NMJ
    • ⊕ of nicotinic receptors in VTA ⇒ dopamine release in the nucleus accumbens ⇒ activates reward pathway
    • Inhaled and has a short half-life
    • High addiction potential
  • CNS Effects:
    • Nicotine is rapidly distributed into the brain
    • ⊕ of nicotinic receptors in the CNS has anxiolytic effects, ↑ arousal, and suppresses appetite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nicotine

Metabolism

A
  • Parent compound w/ short half-life
  • Metabolized to the active metabolite cotinine ⇒ half-life of 2 hours
  • Tars in cigarette smoke cause an induction of cytochrome p450↑ metabolism of nicotine + drugs (ex. B-blockers)
    • Smokers may require higher doses of these agents
17
Q

Nicotine

Withdrawal

A
  • Leads to irritability, anxiety, autonomic arousal, and intense craving
  • Treatment:
    • Nicotine replacement therapy
      • Chewing gum, lozenges, or transdermal patches
    • Varenicline
      • Partial agonist @ α4β2 nicotinic receptor
    • Bupropion (antidepressant)
      • Enhances dopamine release in the nucleus accumbens
18
Q

Nicotine

Long-term Effects

A

Cancer, heart disease, and COPD

19
Q

Amphetamine/Cocaine

Mechanism of Action

A

CNS stimulant

  • Cocaine
    • ⊗ Reuptake monoamines in the presynaptic terminal
    • Most effective at blocking reuptake of dopamine
    • Can also block NE and 5-HT transporters @ higher concentrations
  • Amphetamine
    • Substrate for the monoamines transporter
    • Enters the synaptic terminal ⇒ displaces primarily NE from the vesicles
    • NE then exits the synaptic terminal through the reversal of the transporter
    • Amphetamine causes the release of norepinephrine
    • Other neurotransmitter systems are affected but less so
20
Q

Amphetamine/Cocaine

CNS Effects

A
  • Locus ceruleus contains noradrenergic cell bodies
    • Diffuse projections throughout the brain
    • Descending projections to the medulla and the spinal cord
    • Cocaine and amphetamine enhance the actions of norepinephrine released from these projections ⇒ ↑ arousal and vigilance
  • Also enhance the release of dopamine within the nucleus accumbensactivates the reward pathway
    • Initial effects: profound sense of well-being, energy, and optimism
      • Contributes to abuse potential
    • Initial effects can progress to psychomotor agitation, paranoia and psychosis
    • Cocaine has more euphoric effects initially d/t release of dopamine ⇒ effect is relatively short lived
    • Cocaine can alter tactile sensation, causing the user to feel insects crawling below the skin ⇒ “cocaine bugs”
    • Effects of amphetamine are more prolonged
21
Q

Amphetamine/Cocaine

Withdrawal

A
  • Characterized by listlessness, drowsiness, and depressed mood, dysphoria and anhedonia
  • Sx occur upon w/d of the drug but is not classic w/d because re-administration of drug does not alleviate sx
  • W/d sx may occur in the presence of the drug, because of a phenomenon called tachyphylaxis
    • Occurs when the target becomes less responsive to the drug
    • Most likely due to depletion of neurotransmitters
  • Very difficult to treat because of the tachyphylaxis and other neuroadaptive factors
22
Q

Methamphetaminea

A

CNS stimulant

  • _Related to amphetamin_e, however, by comparison, it causes more dopamine release
  • Crystal form of methamphetamine can be smoked, resulting, very rapid rate of dopamine release in the nucleus accumbens
    • Enhances the abuse potential of the drug
  • Cheap cost and wide availability have led to widespread abuse of this agent
23
Q

3,4-methylenedioxymethamphetamine

(MDMA)

A

CNS stimulant

  • Also known as “ecstasy”
  • Similar effects to methamphetamine on dopamine
  • Primary effect is ↑ serotonin release and synthesis and reuptake of serotonin
  • Actions ↑ serotonin release but ultimately lead to the depletion of serotonin
  • May be neurotoxic to a subpopulation of serotonergic neurons
  • This agent has stimulant as well as hallucinogenic properties
24
Q

Caffeine

A

CNS stimulant

  • A methylxanthine
    • Found in many beverages and chocolate
  • presynaptic adenosine receptorsnormally release of dopamine and norepinephrine
    • Results in enhanced dopamine/norepinephrine releasestimulatory effect
  • Adenosine is thought to promote sleep, so caffeine works to counteract this effect
  • W/d sx are mild, but may include lethargy, irritability and headache
25
Q

Cannabis

Mechanism of Action

A

Psychoactive Drug

  • Active component is tetrahydrocannabinol (THC)
    • Partial agonist at the cannabinoid receptor (CB1)
  • THC mimics anandamide ⇒ endogenous ligand derived from arachidonic acid
    • Made in activated dopaminergic neurons of VTA by diacylglycerol lipase
    • Acts as a retrograde neurotransmitter on presynaptic GABAergic neuron ⇒ ⊗ their inhibitory action
  • Disinhibition of these interneurons ⇒ release of dopamine within the nucleus accumbens
26
Q

Cannabis

CNS Effects

A
  • Rapidly causes euphoria, laughter, giddiness, and a feeling of detachment
  • After 1-2 hours, cognitive functions are compromised and individual has trouble concentrating
    • Known as the “mellowing phase
  • High doses cause panic reactions, perceptual distortions, and changes in perception of reality
  • This drug or its synthetic derivative, dronabinol is used to treat nausea and stimulate appetite
27
Q

Cannabis

Tolerance & Withdrawal

A
  • Tolerance can occur via the down regulation of CB1 receptors
  • W/d sx are mild because of the large volume of distribution and long half-life
    • Sx can include insomnia, loss of appetite, irritability and anxiety
    • Treatment: CB1 antagonist was taken off the market because of adverse effects
28
Q

Synthetic Cannabinoids

A
  • Sometimes called K2 or Spice products
  • Normally marketed as herbal material laced w/ synthetic cannabinoid (not a natural product)
  • Synthetic derivatives are full agonists at the CB1 receptor ⇒ more potent than THC
  • These are not safe or legal alternatives to marijuana
  • Significant CNS and cardiovascular toxicity
29
Q

Lysergic Acid (LSD)

A

Synthetic ergot derivative

  • serotonin-2 receptors in cortical layers glutamate release
    • Mesolimbic dopamine system is not targeted
  • Usually causes visual hallucinations but may also cause other types
  • Some report synesthesia ⇒ condition where one sensory modality assumes the characteristics of another
    • Ex. colors may be heard
  • Little effect on cognitive function or arousal
  • Mood changes are usually pleasant but can be terrifying and cause a panic attack ⇒ “bad trip”
30
Q

Mescaline

A

Found in the Peyote cactus

Similar mechanism of action to LSD

31
Q

Psilocybin

A

From the species of mushroom Psilocybin coprophilia that grows on cow dung

Similar mechanism of action to LSD

32
Q

Phencyclidine

(PCP)

A
  • Originally developed as a dissociative anesthetic, similar to ketamine
    • Taken off the market due to post-anesthetic hallucinations and delirium
  • It sometimes called “angel dust” because it may be sprinkled on other products
  • NMDA glutamate receptors on GABA interneuronsdisinhibition of pyramidal neurons↑ glutamate in the cortex
  • It can cause euphoria, hallucinations, and psychotic behavior
  • Sometimes accompanied hostility and violent behavior
  • Thought to provide a model for psychotic behavior